| Autor: |
Yaru Tong, Yuzheng Zhuge, Ming Zhang, Zexue Qi, Wei Wu, Jinjun Chen, Fuliang He, Xiaofeng Zhang, Feng Zhang, Taishun Li, Bin Zhang, Wei Zhang, Qin Yin, Pengxu Ding, Guangchuan Wang |
| Rok vydání: |
2022 |
| DOI: |
10.21203/rs.3.rs-1730035/v1 |
| Popis: |
Background Budd-Chiari syndrome (BCS), especially BCS-hepatic vein occlusion type (BCS-HV), and Pyrrolizidine alkaloids-induced hepatic sinusoidal obstructive syndrome (PA-HSOS) share many clinical characteristics. In this study, we comprehensively compare the two diseases to identify key characteristics. Methods 139 patients with BCS-HV and 257 PA-HSOS patients admitted to six hospitals between January 2014 and October 2021 were retrospectively analyzed. The two groups were then comprehensively compared and analyzed clinically. Results Among the 139 BCS-HV and 257 PA-HSOS patients, the mean age and the median time from symptom onset to the first visit have a statistical difference. 257 PA-HSOS patients all had a history of taking PA-containing plants, while no patients in the BCS-HV group were exposed to PA-containing plants (p |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
